Suzetrigine for Treatment and Reduction of Intense Discomfort After knEe Replacement PAIN

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Total Knee Replacement Surgery, Post-operative Pain

In brief

This is a prospective, randomized study. The purpose of this study is to evaluate if the addition of Suzetrigine, a new pain medication, to well established peri-operative pain regimen used for total knee replacement surgery will effect pain control. 1. Does Suzetrigine given pre-operatively decrease the total opioid consumed after total knee replacement surgery? 2. Dose Suzetrigine given pre-operatively decrease the visual analog pain scale pain scores after total knee replacement surgery? Study participants will be randomly assigned to receive either Suzetrigine medication or placebo medication.

Key facts

Study ID
NCT07548385
Run by
Icahn School of Medicine at Mount Sinai
People needed
235
Starts
2026-04-01
Expected to finish
2027-02-23
Last updated by the study team
2026-04-23

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.